Tech Company Financing Transactions
PolyMedix Funding Round
Dutchess Equity Fund and private investors participated in a $10 million funding round for PolyMedix. The financing was announced by the company on 5/20/2009.
Transaction Overview
Company Name
Announced On
5/20/2009
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
170 N. Radnor Chester Road 300
Radnor, PA 19087
USA
Radnor, PA 19087
USA
Phone
Website
Email Address
Overview
PolyMedix focuses on developing novel high-value therapeutic drug products for serious, life-threatening acute disorders. We attack these challenges with biomimetics - novel small molecule compounds and polymers which mimic the activity of proteins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Landekic
Chief Financial Officer
Edward Smith
Chief Medical Officer
Daniel Jorgensen
VP - Bus. Development
Steffen Helmling
VP - R & D
Richard Scott
Browse more venture capital transactions:
Prev: 5/19/2009: GreenBytes venture capital transaction
Next: 5/20/2009: Axcient venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs